The burden of hepatic diseases is substantial, demanding advanced therapeutic options. Regenerative therapies represent a remarkably exciting avenue, offering the potential to restore damaged liver tissue and improve clinical outcomes. Currently, research focuses on several methods, including the introduction of mesenchymal cellular entities direct